No Data
No Data
No Data
MediPharm Labs Corp. Brief: Acquiring Advanced Medical Cannabis Delivery Method Technology From Remidose Aerosols
MediPharm Labs Corp. Brief: Anticipates Further Improvement on Profitability in 2024 With Plans Being Implemented to Improve Adjusted EBITDA by a Further $1-$2 Million
MediPharm Labs Corp. Brief: Revenue Increased 67% to $9.8 Million During the Three Months Ended March 31, 2024, Versus Revenue for the Same Quarter in 2023 of $5.8 Million
MediPharm Labs Narrows Q4 Loss, Revenue Grows
MediPharm Labs Corp. Brief: Q4 Revenue $9.131 Million; Says Annual Revenue and Adjusted EBITDA Improve by 50%
MediPharm Labs Corp. Brief: Says "Historic Change Is a Significant Positive Step in Removing the Stigma Related to Medical Cannabis"